-
Something wrong with this record ?
Nádorové markery a jejich využití v klinické praxi
[Tumor markers and their use in clinical practice]
I. Machová, A. Brázdová, M. Fusek, J. Zídková
Chemické listy.
2012 ;
106 (1) :
16-19.
Language Czech Country Czech Republic
Persistent link
https://www.medvik.cz/link/bmc12013256
- MeSH
- alpha-Fetoproteins MeSH
- Clinical Medicine MeSH
- Biomarkers, Tumor MeSH
- Prostate-Specific Antigen MeSH
- Sensitivity and Specificity MeSH
- Tissue Polypeptide Antigen MeSH
Tumor markers known also as cancer or oncological markers are substances produced either by tumor or normal cells as a response to the presence of cancer . The markers are used for the detection, diagnosis, prognosis and control of treatment. There is no absolutely specific or universal cancer marker; therefore different markers for different cancer types are used in clinical practice. A problematic feature of cancer markers is their falsely positive results under physiological and non-cancer conditions.
Tumor markers and their use in clinical practice
Bibliography, etc.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12013256
- 003
- CZ-PrNML
- 005
- 20120420132824.0
- 007
- ta
- 008
- 120420s2012 xr f 000 0cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Machová, Iva, $d 1987- $7 xx0155464 $u Ústav organické chemie a biochemie AV ČR, v.v.i., Praha
- 245 10
- $a Nádorové markery a jejich využití v klinické praxi / $c I. Machová, A. Brázdová, M. Fusek, J. Zídková
- 246 31
- $a Tumor markers and their use in clinical practice
- 504 __
- $a Literatura $b 20
- 520 9_
- $a Tumor markers known also as cancer or oncological markers are substances produced either by tumor or normal cells as a response to the presence of cancer . The markers are used for the detection, diagnosis, prognosis and control of treatment. There is no absolutely specific or universal cancer marker; therefore different markers for different cancer types are used in clinical practice. A problematic feature of cancer markers is their falsely positive results under physiological and non-cancer conditions.
- 650 _2
- $a nádorové biomarkery $7 D014408
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a prostatický specifický antigen $7 D017430
- 650 _2
- $a tkáňový polypeptidový antigen $7 D019396
- 650 _2
- $a alfa-fetoproteiny $7 D000509
- 650 _2
- $a klinické lékařství $7 D015510
- 700 1_
- $a Brázdová, Andrea. $7 ntk2015859863 $u Ústav biochemie a mikrobiologie, Vysoká škola chemickotechnologická, Praha
- 700 1_
- $a Fusek, Martin, $d 1958- $7 jo2007286435 $u Ústav biochemie a mikrobiologie, Vysoká škola chemickotechnologická, Praha
- 700 1_
- $a Zídková, Jarmila $7 xx0074470 $u Ústav biochemie a mikrobiologie, Vysoká škola chemickotechnologická, Praha
- 773 0_
- $t Chemické listy $x 0009-2770 $g Roč. 106, č. 1 (2012), s. 16-19 $w MED00011010
- 856 41
- $u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/1008/1008 $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 1918 $c 395 $y 2
- 990 __
- $a 20120420105415 $b ABA008
- 991 __
- $a 20120420133058 $b ABA008
- 999 __
- $a ok $b bmc $g 906736 $s 770276
- BAS __
- $a 3
- BMC __
- $a 2012 $b 106 $c 1 $d 16-19 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
- LZP __
- $a 2012-20/dkjs
